These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6117612)

  • 21. Clinical evaluation of bisoprolol in patients with hypertension: interim report.
    Ikeda M; Inagaki Y; Iimura O; Kuramoto K; Takeda T
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S139-42. PubMed ID: 2439785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1993 Dec; 6(12):1016-24. PubMed ID: 7907884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of beta-adrenergic receptor blocking agents on blood pressure in conscious hypertensive rats.
    Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1975 Feb; 25(1):25-34. PubMed ID: 239267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure lowering action and alpha-adrenolytic effect of adimolol in rats.
    Palluk R; Hoefke W
    Arch Int Pharmacodyn Ther; 1989; 301():215-27. PubMed ID: 2576194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative studies of antihypertensive effects of several beta-blocking agents in conscious rats (author's transl)].
    Ozawa H; Watanabe H; Chen CS
    Nihon Yakurigaku Zasshi; 1978 Jan; 74(1):139-44. PubMed ID: 25230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular response to adrenergic stimulation during treatment with tertatolol. A new non-cardioselective beta-blocking agent in primary hypertensive patients.
    Fasano ML; Gaeta I; De Simone G; Iannuzzi R; Ferrara LA
    Jpn Heart J; 1991 Jul; 32(4):435-44. PubMed ID: 1683411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR.
    Nakahara H; Nakazawa M; Takeda K; Imai S
    Jpn J Pharmacol; 1985 Dec; 39(4):487-92. PubMed ID: 2419613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antihypertensive effect of betaxolol, a cardioselective beta-adrenoceptor antagonist, in experimental hypertensive rats].
    Bessho H; Suzuki J; Narimatsu A; Tobe A
    Nihon Yakurigaku Zasshi; 1990 Jun; 95(6):347-54. PubMed ID: 1974238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pafenolol, a new beta 1-selective blocking agent, in mild hypertension. Result of an inpatient study and a subsequent outpatient follow-up.
    Sigurdsson JA; Bengtsson C; Bjurö T
    Eur J Clin Pharmacol; 1984; 26(5):549-53. PubMed ID: 6147255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
    Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Beta receptors and renin release.
    Amery A; Billiet L; Fagard R
    N Engl J Med; 1974 Jan; 290(5):284. PubMed ID: 4148766
    [No Abstract]   [Full Text] [Related]  

  • 33. Dose-effect relationship and long-term effects of bisoprolol in mild to moderate hypertension.
    Weiner L; Frithz G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S106-12. PubMed ID: 2439780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the new angiotensin II type 1 receptor antagonist KRH-594 on several types of experimental hypertension.
    Inada Y; Murakami M; Kaido K; Nakao K
    Arzneimittelforschung; 1999 Jan; 49(1):13-21. PubMed ID: 10028373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive activity of four blocking agents in spontaneously hypertensive rats.
    Roba J; Lambelin G; De Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):182-90. PubMed ID: 4404933
    [No Abstract]   [Full Text] [Related]  

  • 36. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
    Hansson BG; Hökfelt B
    Eur J Clin Pharmacol; 1975 Oct; 9(1):9-19. PubMed ID: 9298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
    Ponchon P; Elghozi JL
    Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose response studies of bevantolol in hypertensive patients.
    Okawa KK
    Angiology; 1986 Mar; 37(3 Pt 2):233-8. PubMed ID: 2871783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
    Noshiro T; Miura Y; Yoshinaga K; Iimura O; Inagaki Y; Saruta T; Ishii M; Yamazaki N; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):240-5. PubMed ID: 7620695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.